Old Web
English
Sign In
Acemap
>
authorDetail
>
Charles Jack Robbins
Charles Jack Robbins
Yale University
Oncology
Internal medicine
Medicine
Pembrolizumab
PD-L1
2
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Programmed Death-Ligand 1 Tumor Proportion Score and Overall Survival From First-Line Pembrolizumab in Patients With Nonsquamous Versus Squamous NSCLC
2021
Journal of Thoracic Oncology
Deborah B. Doroshow
Wei Wei
Swati B. Gupta
Jon Zugazagoitia
Charles Jack Robbins
Blythe J.S. Adamson
David L. Rimm
Show All
Source
Cite
Save
Citations (1)
PD-L1 tumor proportion score and clinical benefit from first-line pembrolizumab in patients with advanced nonsquamous versus squamous non-small cell lung cancer (NSCLC).
2020
Journal of Clinical Oncology
Deborah B. Doroshow
Wei Wei
Jon Zugazagoitia
Charles Jack Robbins
Swati Gupta
Blythe J.S. Adamson
David L. Rimm
Show All
Source
Cite
Save
Citations (3)
1